NCT02262533View on ClinicalTrials.gov

Phase 1 Drug Interaction Study of Apixaban and Atenolol in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions

N/A - Healthy Subjects

Interventions

DRUG

Apixaban

DRUG

Atenolol

Trial Locations (1)

08690

Bms Clinical Research Center, Hamilton

Sponsors

Lead Sponsor

Bristol-Myers Squibb

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY